Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by BearDownAZon Nov 03, 2019 2:13pm

241 Views

Post# 30302557

RE:RE:RE:RE:Question for BearDownAZ ?

"Bear, i hope the last Late breaking spot gives more attention and highlight to
possible positive trial results from world opinion leaders, media attention, and press attention"

Yes indeed. This will be the most high profile presentation that Resverlogix has ever given. DDr. Kausik Ray will deliver the AHA late breaking presentation on BETonMACE. See details in that link.

Once the presentation starts, the AHA embargo will be lifted. It is likely that the peer reviewed BETonMACE publication is already written and will be simultaneously published (i.e. NEJM, Lancet) at the time of the late breaker once the embargo is lifted. Also very likely that prior to the late breaking presentation that media interviews, news articles, AHA press releases, will already be ready to go (under embargo) and published at time of presentation. Rest assured, there will be lots of coverage.

If anyone is interested, there are real time live-streaming as well as on demand options for the AHA 2019 meeting (not free) that would allow one to view the AHA presentations including the late-breakers.

https://professional.heart.org/professional/EducationMeetings/MeetingsLiveCME/ScientificSessions/UCM_488605_Sessions-LIVE.jsp

https://aha.ondemand.org/aha/live/34/page/294

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale